Hovione reported today recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey.
C&EN, February 12, 2018
LAB BLOG: Inhalation Sciences, February 8, 2018
Engineers Journal, December 5, 2017
A Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel